We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current APVO market cap is 386.76k. The company's latest EPS is USD -32.6376 and P/E is -0.02.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.78M | -7.68M | -7.76M | -8.18M | -6.56M |
| Net Income | -7.64M | -4.64M | 2.77M | -7.95M | -6.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 32.42M | 4.31M | 12.29M | 3.11M | 0 |
| Operating Income | -42.6M | -27.49M | -21.4M | -28.64M | -28.88M |
| Net Income | -40.45M | -17.75M | -28.46M | 8.03M | -17.41M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 31.7M | 34.22M | 34.97M | 28.91M | 27.13M |
| Total Liabilities | 15.93M | 16.24M | 11.71M | 12.66M | 12.41M |
| Total Equity | 15.76M | 17.97M | 23.26M | 16.25M | 14.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 53.41M | 53.55M | 56.6M | 34.22M | 24.84M |
| Total Liabilities | 41.57M | 36.95M | 55.39M | 16.24M | 12.62M |
| Total Equity | 11.84M | 16.59M | 1.22M | 17.97M | 12.22M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.08M | -21.02M | 4.57M | -237k | -6.48M |
| Investing | -29k | -29k | N/A | N/A | N/A |
| Financing | -8.61M | -2.62M | -1.87M | -1.39M | 2.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -42.38M | -29.32M | -21.68M | -21.02M | -11.73M |
| Investing | 4.1M | 28.03M | -713k | -29k | N/A |
| Financing | 20.15M | 23.87M | 26.16M | -2.62M | 6M |
| Market Cap | 386.76k |
| Price to Earnings Ratio | -0.02 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.02 |
| Price to Book Ratio | 0.03 |
| Dividend Yield | - |
| Shares Outstanding | 533.46k |
| Average Volume (1 week) | 489.71k |
| Average Volume (1 Month) | 530k |
| 52 Week Change | -99.13% |
| 52 Week High | 91.96 |
| 52 Week Low | 0.70 |
| Spread (Intraday) | 0.03 (4.18%) |
| Company Name | Aptevo Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.aptevotherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
